Drug Information

Drug General Information
Drug ID
D07MAF
Former ID
DNC009794
Drug Name
3-(dimethylamino)-1-(4-heptylphenyl)propan-1-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530166]
Formula
C18H29NO
Canonical SMILES
CCCCCCCC1=CC=C(C=C1)C(=O)CCN(C)C
InChI
1S/C18H29NO/c1-4-5-6-7-8-9-16-10-12-17(13-11-16)18(20)14-15-19(2)3/h10-13H,4-9,14-15H2,1-3H3
InChIKey
ANCSLKGKDIAGLN-UHFFFAOYSA-N
PubChem Compound ID
21653696
Target and Pathway
Target(s) Thyroid hormone receptor beta-1 Target Info Inhibitor [530166]
Potassium voltage-gated channel subfamily H member 2 Target Info Inhibitor [530166]
KEGG Pathway Neuroactive ligand-receptor interaction
Thyroid hormone signaling pathway
Pathway Interaction Database RXR and RAR heterodimerization with other nuclear receptor
PathWhiz Pathway Muscle/Heart Contraction
Reactome Nuclear Receptor transcription pathwayR-HSA-1296072:Voltage gated Potassium channels
WikiPathways SIDS Susceptibility Pathways
Hematopoietic Stem Cell Differentiation
Nuclear ReceptorsWP706:SIDS Susceptibility Pathways
Potassium Channels
References
Ref 530166J Med Chem. 2009 Jul 9;52(13):3892-901.Improvement of pharmacological properties of irreversible thyroid receptor coactivator binding inhibitors.
Ref 530166J Med Chem. 2009 Jul 9;52(13):3892-901.Improvement of pharmacological properties of irreversible thyroid receptor coactivator binding inhibitors.